{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:50:18Z","timestamp":1793073018704,"version":"4.5.0"},"reference-count":349,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.pneurobio.2015.09.011","type":"journal-article","created":{"date-parts":[[2015,10,17]],"date-time":"2015-10-17T21:45:35Z","timestamp":1445118335000},"page":"149-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":199,"special_numbering":"C","title":["Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms"],"prefix":"10.1016","volume":"155","author":[{"given":"Rosario","family":"Moratalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Khairnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Simola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Granado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ruben","family":"Garc\u00eda-Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Francesca","family":"Porceddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Tizabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2015.09.011_bib0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/cne.20994","article-title":"Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in dark agouti rat: temporal, spatial, and cellular patterns","volume":"497","author":"Adori","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.nbd.2009.09.002","article-title":"Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease","volume":"36","author":"Afonso-Oramas","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0015","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1097\/00001756-199911260-00039","article-title":"Alpha-lipoic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity","volume":"10","author":"Aguirre","year":"1999","journal-title":"NeuroReport"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0020","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0022-3565(25)12160-5","article-title":"Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents","volume":"275","author":"Albers","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-3565(25)08045-0","article-title":"The comparative physiological actions of the dl-B-phenylisopropylamines. I. Pressor effect and toxicity","volume":"47","author":"Alles","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/glia.1106","article-title":"Immune function of microglia","volume":"36","author":"Aloisi","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0035","doi-asserted-by":"crossref","first-page":"10203","DOI":"10.1523\/JNEUROSCI.2645-07.2007","article-title":"Monoamine oxidase-B mediates ecstasy-induced neurotoxic effects to adolescent rat brain mitochondria","volume":"27","author":"Alves","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0040","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.13104","article-title":"Methamphetamine acutely inhibits voltage-gated calcium channels but chronically up-regulates L-type channels","author":"Andres","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/jnc.12114","article-title":"Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA","volume":"125","author":"Angoa-P\u00e9rez","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1196\/annals.1316.022","article-title":"Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum","volume":"1025","author":"Angulo","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11481-012-9420-x","article-title":"MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase","volume":"8","author":"Anneken","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0060","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.nbd.2011.11.005","article-title":"Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine","volume":"45","author":"Ares-Santos","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0065","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/joim.12049","article-title":"The role of dopamine receptors in the neurotoxicity of methamphetamine","volume":"273","author":"Ares-Santos","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0070","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/npp.2013.307","article-title":"Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining","volume":"39","author":"Ares-Santos","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0075","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/tx010011l","article-title":"Serotonergic neurotoxicity of 3,4-(+\/\u2212)-methylenedioxyamphetamine and 3,4-(+\/\u2212)-methylenedioxymethamphetamine (Ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase","volume":"14","author":"Bai","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0080","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00204-013-1147-9","article-title":"\u201cEcstasy\u201d-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites","volume":"88","author":"Barbosa","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0085","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/cddis.2011.17","article-title":"IFN-\u03b3 signaling, with the synergistic contribution of TNF-\u03b1, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease","volume":"2","author":"Barcia","year":"2011","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0090","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-3565(25)39191-3","article-title":"3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites","volume":"242","author":"Battaglia","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0095","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1523\/JNEUROSCI.22-06-02135.2002","article-title":"Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity","volume":"22","author":"Battaglia","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0100","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/npp.2010.244","article-title":"Human Ecstasy use is associated with increased cortical excitability: an fMRI study","volume":"36","author":"Bauernfeind","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0110","doi-asserted-by":"crossref","first-page":"e28946","DOI":"10.1371\/journal.pone.0028946","article-title":"Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways","volume":"6","author":"Beauvais","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2008.08.001","article-title":"A new brain area affected by 3,4 methylenedioxymethamphetamine: a microdialysis-biotelemetry study","volume":"596","author":"Benamar","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/npp.2012.178","article-title":"Brain serotonin function in MDMA (ecstasy) users: evidence for persisting neurotoxicity","volume":"38","author":"Benningfield","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0125","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1360-0443.2010.02948.x","article-title":"Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin","volume":"105","author":"Benzenh\u00f6fer","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2006.02.003","article-title":"5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease","volume":"23","author":"Bezard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0135","series-title":"Handbook of Neurotoxicity","article-title":"Methamphetamine and MDMA neurotoxicity: biochemical and molecular mechanisms","author":"Bisagno","year":"2014"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1527-3458.2001.tb00207.x","article-title":"SCH 23390 the first selective dopamine D1-like receptor antagonist","volume":"7","author":"Bourne","year":"2001","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-8993(01)03051-7","article-title":"Phenobarbital and dizocilpine can block methamphetamine-induced neurotoxicity in mice by mechanisms that are independent of thermoregulation","volume":"919","author":"Bowyer","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/syn.20478","article-title":"Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood\u2013brain barrier in the caudate-putamen from acute methamphetamine exposure","volume":"62","author":"Bowyer","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0160","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0091-3057(93)90520-4","article-title":"Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity","volume":"45","author":"Brodkin","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0165","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/syn.20130","article-title":"Interactions of dopamine D1 and D2 receptor antagonists with d-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions","volume":"56","author":"Broening","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0170","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0022-3565(25)10672-1","article-title":"Effects of sulpiride and SCH 23390 on methamphetamine-induced changes in body temperature and lethality","volume":"274","author":"Bronstein","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0163-7258(03)00052-4","article-title":"Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress","volume":"99","author":"Brown","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0180","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1471-4159.2005.03379.x","article-title":"Methamphetamine induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite","volume":"95","author":"Brown","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0185","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1471-4159.2006.03902.x","article-title":"Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN\/OFQ expression","volume":"98","author":"Brown","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0190","first-page":"279","article-title":"Excitatory amino acids and neurotoxicity","volume":"8","author":"Bruno","year":"1993","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0195","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00259-005-1850-8","article-title":"Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users","volume":"33","author":"Buchert","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0200","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0306-4522(93)90333-B","article-title":"Relative loss of the striatal striosome compartment, defined by calbindin-D28k immunostaining, following developmental hypoxic-ischemic injury","volume":"56","author":"Burke","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0205","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1385\/FSMP:2:2:115","article-title":"Neuropathological alterations in drug abusers: the involvement of neurons, glial, and vascular systems","volume":"2","author":"B\u00fcttner","year":"2006","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2990.2010.01131.x","article-title":"Review: the neuropathology of drug abuse","volume":"37","author":"B\u00fcttner","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0197-0186(97)00031-4","article-title":"Free radicals and the pathobiology of brain dopamine systems","volume":"32","author":"Cadet","year":"1998","journal-title":"Neurochem. Int."},{"issue":"Suppl. 3","key":"10.1016\/j.pneurobio.2015.09.011_bib0220","first-page":"IS57","article-title":"Involvement of free radicals in MDMA-induced neurotoxicity in mice","volume":"152","author":"Cadet","year":"2001","journal-title":"Ann. Med. Interne (Paris)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0225","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/syn.20512","article-title":"The combination of methamphetamine and of the HIV protein, Tat, induces death of the human neuroblastoma cell line, SH-SY5Y","volume":"62","author":"Cai","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0230","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1038\/sj.npp.1300859","article-title":"Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype?","volume":"30","author":"Caligiuri","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0235","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/mds.23263","article-title":"Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders","volume":"25","author":"Callaghan","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2011.06.013","article-title":"Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs","volume":"120","author":"Callaghan","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0245","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0248-4900(03)00089-3","article-title":"Evolution and cell biology of dopamine receptors in vertebrates","volume":"95","author":"Callier","year":"2003","journal-title":"Biol. Cell"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.105.092577","article-title":"Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia","volume":"316","author":"Capela","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0255","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neuroscience.2006.01.007","article-title":"Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor dependent and potentiated under hyperthermia","volume":"139","author":"Capela","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0260","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12035-009-8064-1","article-title":"Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview","volume":"39","author":"Capela","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0265","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0006-8993(00)02107-7","article-title":"Time-course of methamphetamine-induced neurotoxicity in rat caudate-putamen after single-dose treatment","volume":"863","author":"Cappon","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0270","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12640-014-9505-9","article-title":"Methamphetamine-induced toxicity in indusium griseum of mice is associated with astro- and microgliosis","volume":"27","author":"Carmena","year":"2015","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0275","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1360-0443.2006.01782.x","article-title":"Structural and metabolic brain changes in the striatum associated with methamphetamine abuse","volume":"102","author":"Chang","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0280","doi-asserted-by":"crossref","first-page":"39317","DOI":"10.1074\/jbc.M403891200","article-title":"D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade","volume":"279","author":"Chen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0285","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2013.05.016","article-title":"RNA interference targeting \u03b1-synuclein attenuates methamphetamine-induced neurotoxicity in SH-SY5Y cells","volume":"1521","author":"Chen","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0290","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.neuropharm.2008.04.003","article-title":"Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents","volume":"54","author":"Chipana","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0295","first-page":"228","article-title":"Methamphetamine abuse during pregnancy and its health impact on neonates born at Siriraj Hospital, Bangkok, Thailand","volume":"35","author":"Chomchai","year":"2010","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0300","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/mds.22915","article-title":"Parkinsonism in patients with a history of amphetamine exposure","volume":"25","author":"Christine","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0305","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1471-4159.2010.06922.x","article-title":"Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release","volume":"115","author":"Chu","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0310","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/157016212802138832","article-title":"HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS","volume":"10","author":"Cisneros","year":"2012","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0315","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1476-5381.1995.tb15037.x","article-title":"The hyperthermic and neurotoxic effects of \u201cecstasy\u201d (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in the dark agouti (DA) rat, a model of the cyp2d6 poor metabolizer phenotype","volume":"115","author":"Colado","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0320","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/sj.bjp.0701859","article-title":"Role of hyperthermia in the protective action of chlomethiazole against MDMA (\u201cecstasy\u201d)-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR","volume":"124","author":"Colado","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0325","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/sj.bjp.0704435","article-title":"A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019) on dopamine neurones in mouse brain","volume":"134","author":"Colado","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0330","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0022-5347(25)00317-9","article-title":"Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain","volume":"241","author":"Commins","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0335","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/mds.25646","article-title":"MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice","volume":"28","author":"Costa","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0340","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1007\/s00213-014-3536-z","article-title":"MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex","volume":"231","author":"Costa","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0345","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pnpbp.2013.09.021","article-title":"Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat","volume":"48","author":"Cox","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0350","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(99)00538-5","article-title":"Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines","volume":"381","author":"Cozzi","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0355","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.brainres.2006.01.017","article-title":"Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats","volume":"1077","author":"Crawford","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0360","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1523\/JNEUROSCI.14-04-02260.1994","article-title":"Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress","volume":"14","author":"Cubells","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0365","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1046\/j.1360-0443.2003.00450.x","article-title":"Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions","volume":"98","author":"Cunningham","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0370","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.socscimed.2007.12.006","article-title":"Impact of methamphetamine precursor legislation, a suppression policy, on the demand for drug treatment","volume":"66","author":"Cunningham","year":"2008","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0375","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1360-0443.2008.02208.x","article-title":"Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting","volume":"103","author":"Cunningham","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0380","series-title":"Amphetamine-Related Emergency Admissions: Trends and Regional Variations in California (1985\u20131994)","author":"Cunningham","year":"1996"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0385","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2014.10.027","article-title":"Methamphetamine\/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment","volume":"146","author":"Curtin","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0390","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s002130050664","article-title":"Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or \u201cecstasy\u201d) but not by fenfluramine","volume":"138","author":"Dafters","year":"1998","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0395","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.biopsych.2009.04.025","article-title":"Genetic inactivation of dopamine D1 but not D2 receptors inhibits l-DOPA-induced dyskinesia and histone activation","volume":"66","author":"Darmopil","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0400","doi-asserted-by":"crossref","first-page":"14664","DOI":"10.1073\/pnas.0907299106","article-title":"Restriction of dopamine signaling to the dorsolateral striatum is sufficient for many cognitive behaviors","volume":"106","author":"Darvas","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0405","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1523\/JNEUROSCI.4576-09.2010","article-title":"Restricting dopaminergic signaling to either dorsolateral or medial striatum facilitates cognition","volume":"30","author":"Darvas","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0410","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2004.06.011","article-title":"Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study","volume":"56","author":"Daumann","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0415","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00213-004-2002-8","article-title":"Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users","volume":"180","author":"Daumann","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0420","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1099-1077(199705\/06)12:3<221::AID-HUP854>3.0.CO;2-C","article-title":"Ecstasy (MDMA) in recreational users: self-reported psychological and physiological effects","volume":"12","author":"Davison","year":"1997","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0425","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1749-6632.2000.tb05199.x","article-title":"Pharmacology of MDMA in humans","volume":"914","author":"de la Torre","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0430","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00003088-200443030-00002","article-title":"Clinical pharmacokinetics of amfetamine and related substances monitoring in conventional and non-conventional matrices","volume":"43","author":"de la Torre","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0435","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2008.12.002","article-title":"Getting specialized: presynaptic and postsynaptic dopamine D2 receptors","volume":"9","author":"De Mei","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0440","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.biopsych.2006.09.010","article-title":"Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb","volume":"61","author":"Deng","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0445","first-page":"625","article-title":"Methamphetamine. Stimulant of the 1990s?","volume":"153","author":"Derlet","year":"1990","journal-title":"West. J. Med."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0450","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0028-3908(89)90130-5","article-title":"Methamphetamine-induced neuronal damage: a possible role for free radicals","volume":"28","author":"De Vito","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0455","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archgenpsychiatry.2011.156","article-title":"Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users","volume":"69","author":"Di Iorio","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0460","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1471-4159.1999.0720148.x","article-title":"Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum","volume":"72","author":"Dickinson","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0465","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2146\/ajhp060198","article-title":"Oral health of the methamphetamine abuser","volume":"63","author":"Donaldson","year":"2006","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0470","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2014.01.032","article-title":"Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine","volume":"727","author":"Downey","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0475","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/02791072.1986.10472366","article-title":"The psychological and physiological effects of MDMA on normal volunteers","volume":"18","author":"Downing","year":"1986","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0480","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0006-8993(03)03319-5","article-title":"Synthesis, in vitro formation, and behavioural effects of glutathione regioisomers of alpha-methyldopamine with relevance to MDA and MDMA (ecstasy)","volume":"987","author":"Easton","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0485","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/(SICI)1098-2396(199812)30:4<433::AID-SYN10>3.0.CO;2-O","article-title":"Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury","volume":"30","author":"Eisch","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0490","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjp.0706071","article-title":"A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice","volume":"144","author":"Escobedo","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0495","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.nbd.2012.07.012","article-title":"l-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function","volume":"48","author":"Espadas","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0500","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002130000645","article-title":"3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose","volume":"154","author":"Esteban","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0505","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00213-002-1261-5","article-title":"Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice","volume":"166","author":"Fantegrossi","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0510","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuroscience.2007.11.007","article-title":"A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse","volume":"151","author":"Fantegrossi","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0515","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0006-8993(92)91460-V","article-title":"The antagonist MK-801 protects against serotonin depletions induced by methamphetamine 3,4-methylenedioxymethamphetamine and p-chloroamphetamine","volume":"595","author":"Farfel","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0525","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00213-004-1789-7","article-title":"Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics","volume":"173","author":"Farr\u00e9","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0530","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-2999(87)90019-7","article-title":"The effects of selective dopamine receptor agonists and antagonists on body temperature in rats","volume":"133","author":"Faunt","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0535","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxlet.2012.11.015","article-title":"Neurotoxicity of \u201cecstasy\u201d and its metabolites in human dopaminergic differentiated SH-SY5Y cells","volume":"216","author":"Ferreira","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0540","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0304-3940(89)90637-X","article-title":"The N-methyl-d-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats","volume":"105","author":"Finnegan","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0545","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1523\/JNEUROSCI.15-08-05476.1995","article-title":"Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+\/\u2212)3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"15","author":"Fischer","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0550","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1176\/ajp.153.6.812","article-title":"When does amphetamine-induced psychosis become schizophrenia?","volume":"153","author":"Flaum","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0555","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00213-003-1708-3","article-title":"DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy)","volume":"173","author":"Fornai","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0560","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/jcr.2013.0007","article-title":"Contribution of caffeine to the psychostimulant, neuroinflammatory and neurotoxic effects of amphetamine-related drugs","volume":"3","author":"Frau","year":"2013","journal-title":"J. Caffeine Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0565","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/jnc.12060","article-title":"Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility","volume":"124","author":"Frau","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0570","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0892-0362(95)00013-H","article-title":"Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys","volume":"17","author":"Frederick","year":"1995","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0575","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1749-6632.1998.tb08233.x","article-title":"Acute effects of fexfenfluramine (D-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment","volume":"844","author":"Frederick","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0580","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1360-0443.2006.01511.x","article-title":"The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents","volume":"101","author":"Freudenmann","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0585","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neulet.2013.08.039","article-title":"A role for D1 dopamine receptors in striatal methamphetamine-induced neurotoxicity","volume":"555","author":"Friend","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0590","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0028-3908(92)90104-W","article-title":"Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist","volume":"31","author":"Fuller","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0595","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1523\/JNEUROSCI.18-13-04861.1998","article-title":"Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter","volume":"18","author":"Fumagalli","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0600","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1523\/JNEUROSCI.19-07-02424.1999","article-title":"Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice","volume":"19","author":"Fumagalli","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0605","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/hipo.22044","article-title":"Characterization of dopamine D1 and D2 receptor-expressing neurons in the mouse hippocampus","volume":"22","author":"Gangarossa","year":"2012","journal-title":"Hippocampus"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0610","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","article-title":"Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression","volume":"29","author":"Gao","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0615","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.neuro.2006.03.015","article-title":"Amphetamine exposure is elevated in Parkinson's disease","volume":"27","author":"Garwood","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0620","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00401-012-0963-y","article-title":"Nigrostriatal overabundance of \u03b1-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity","volume":"123","author":"Gaugler","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0625","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/342923a0","article-title":"Alternative splicing directs the expression of twoD2 dopamine receptor isoforms","volume":"342","author":"Giros","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0630","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0028-3908(03)00209-0","article-title":"Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats","volume":"45","author":"Golembiowska","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0635","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.nbd.2013.10.008","article-title":"Oleoylethanolamide reduces l-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson's disease","volume":"62","author":"Gonzalez-Aparicio","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0640","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0091-3057(91)90288-D","article-title":"Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat","volume":"38","author":"Gordon","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0645","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.pharep.2014.03.003","article-title":"The effect of caffeine on MDMA-induced hydroxyl radical production in the mouse striatum","volume":"66","author":"G\u00f3rska","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0650","article-title":"The role of adenosine A1 and A2A receptors in the caffeine effect on MDMA-induced DA and 5-HT release in the mouse striatum","author":"G\u00f3rska","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0655","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0278-5846(03)00114-3","article-title":"Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users","volume":"27","author":"Gouzoulis-Mayfrank","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cercor\/bhm026","article-title":"D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-induced arc and zif268 expression in the hippocampus","volume":"18","author":"Granado","year":"2008","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0665","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-4159.2008.05705.x","article-title":"Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice","volume":"107","author":"Granado","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0670","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/syn.20466","article-title":"Early loss of dopaminergic terminals in striosomes after MDMA administration to mice","volume":"62","author":"Granado","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0675","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12640-009-9106-1","article-title":"Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration: early loss of TH in striosomes after methamphetamine","volume":"18","author":"Granado","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0680","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nbd.2011.01.033","article-title":"Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA","volume":"42","author":"Granado","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0685","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/glia.21229","article-title":"Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum","volume":"59","author":"Granado","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0690","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/308052","article-title":"Methamphetamine and Parkinson's disease","author":"Granado","year":"2013","journal-title":"Parkinson's Dis."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0695","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12640-013-9438-8","article-title":"D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice","volume":"25","author":"Granado","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0700","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11481-011-9288-1","article-title":"Methamphetamine-associated psychosis","volume":"7","author":"Grant","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0705","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0028-3908(92)90062-T","article-title":"The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole","volume":"31","author":"Green","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0710","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00213-002-1158-3","article-title":"On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA","volume":"164","author":"Green","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0715","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0720","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejphar.2004.07.006","article-title":"A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response","volume":"500","author":"Green","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0725","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sj.bjp.0706318","article-title":"Studies on the effect of MDMA (\u2018ecstasy\u2019) on the body temperature of rats housed at different ambient room temperatures","volume":"146","author":"Green","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0730","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1476-5381.2011.01819.x","article-title":"Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans","volume":"166","author":"Green","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0735","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/02791072.1986.10472364","article-title":"Subjective reports of the effects of MDMA in a clinical setting","volume":"18","author":"Greer","year":"1986","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0740","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/syn.20952","article-title":"Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity","volume":"65","author":"Gross","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0745","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF00179199","article-title":"Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors","volume":"90","author":"Gudelsky","year":"1986","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0750","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/BF01271253","article-title":"Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin","volume":"102","author":"Gudelsky","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0755","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pbb.2007.10.003","article-title":"Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons","volume":"90","author":"Gudelsky","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0760","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0306-4522(03)00476-7","article-title":"Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity","volume":"122","author":"Guilarte","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0765","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/j.1471-4159.2008.05568.x","article-title":"Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis","volume":"106","author":"Guillot","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0770","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/jpet.110.166660","article-title":"Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation","volume":"335","author":"Hadlock","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0775","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/bja\/ael078","article-title":"Acute toxic effects of \u2018Ecstasy\u2019 (MDMA) and related compounds: overview of pathophysiology and clinical management","volume":"96","author":"Hall","year":"2006","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0780","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1124\/jpet.300.3.1093","article-title":"Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity","volume":"300","author":"Hansen","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0785","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0041-008X(73)80016-X","article-title":"Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals","volume":"25","author":"Hardman","year":"1973","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0790","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00213-002-1131-1","article-title":"Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans","volume":"162","author":"Harris","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0795","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s002130050410","article-title":"Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms","volume":"133","author":"Harrison","year":"1997","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0800","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1523\/JNEUROSCI.19-12-05096.1999","article-title":"Altered serotonin innervations patterns in the forebrain of monkeys treated with (+\/\u2212)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery","volume":"19","author":"Hatzidimitriou","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0805","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.neuroscience.2005.03.051","article-title":"The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity","volume":"135","author":"Hayley","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0810","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00005072-199501000-00013","article-title":"Early loss of neostriatal striosome neurons in Huntington's disease","volume":"54","author":"Hedreen","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0815","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.expneurol.2011.09.035","article-title":"Stress, depression and Parkinson's disease","volume":"233","author":"Hemmerle","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0820","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1460-9568.1989.tb00358.x","article-title":"Localization and quantitative autoradiography of glutamatergic ligand binding sites in chick brain","volume":"1","author":"Henley","year":"1989","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0825","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1369-1600.2010.00259.x","article-title":"Neurotoxicity and persistent cognitive deficits induced by combined MDMA and alcohol exposure in adolescent rats","volume":"15","author":"Hernandez-Rabaza","year":"2010","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0830","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/toxsci\/kft275","article-title":"Glial cell response to 3,4-(+\/\u2212)-methylenedioxymethamphetamine and its metabolites","volume":"138","author":"Herndon","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0835","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1471-4159.1997.69020780.x","article-title":"P53-knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies","volume":"69","author":"Hirata","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0840","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfv014","article-title":"Caspase-11 plays an essential role in methamphetamine-induced dopaminergic neuron apoptosis","author":"Huang","year":"2015","journal-title":"Toxicol Sci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0845","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12640-012-9348-1","article-title":"Neuroinflammation, neurodegeneration, and depression","volume":"23","author":"Hurley","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0850","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","article-title":"Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease","volume":"54","author":"Hurtig","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0855","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1471-4159.2001.00029.x","article-title":"Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase","volume":"76","author":"Imam","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0860","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-3565(25)23487-5","article-title":"3,4-Methylenedioxymethamphetamine (\u201cecstasy\u201d) selectively destroys brain serotonin terminals in rhesus monkeys","volume":"249","author":"Insel","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0865","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1460-9568.2005.03915.x","article-title":"A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets","volume":"21","author":"Iravani","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0870","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00213-002-1320-y","article-title":"Relevance of MDMA (\u201cecstasy\u201d)-induced neurotoxicity to long-lasting psychomotor stimulation in mice","volume":"166","author":"Itzhak","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0875","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00213-009-1699-9","article-title":"Administration of neurotoxic doses of MDMA reduces sensitivity to ethanol and increases GAT-1 immunoreactivity in mice striatum","volume":"207","author":"Izco","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0880","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1016\/S0893-133X(99)00012-3","article-title":"Activity of serotonergic neurons in behaving animals","volume":"21","author":"Jacobs","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0885","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0306-4522(98)00698-8","article-title":"Overexpression of human copper\/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy)","volume":"91","author":"Jayanthi","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0890","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1073\/pnas.0404990102","article-title":"Calcineurin\/NFAT-induced up-regulation of the Fas ligand\/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis","volume":"102","author":"Jayanthi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0895","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/j.drugalcdep.2014.02.280","article-title":"The effects of a low and escalating dosing regimen of methamphetamine on spontaneous behaviors of rhesus macaques (Macaca mulatta)","volume":"140","author":"Jiang","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0900","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejphar.2014.10.043","article-title":"Epigenetic upregulation of alpha-synuclein in the rats exposed to methamphetamine","volume":"745","author":"Jiang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0905","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0269881105053281","article-title":"Acute hypercarbic gas exposure reveals functionally distinct subpopulations of serotonergic neurons in rats","volume":"19","author":"Johnson","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0911","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1471-4159.2012.07864.x","article-title":"Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine","volume":"122","author":"Kelly","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0910","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12640-009-9125-y","article-title":"Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019) in mouse brain","volume":"17","author":"Khairnar","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0915","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/jcr.2014.0006","article-title":"Antagonism of adenosine A1 or A2A receptors amplifies the effects of MDMA on glial activation in the mouse brain: relevance to caffeine\u2013MDMA interactions","volume":"4","author":"Khairnar","year":"2014","journal-title":"J. Caffeine Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0920","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.neuro.2007.07.002","article-title":"Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain","volume":"28","author":"Kindlundh-H\u00f6gberg","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0925","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11481-010-9206-y","article-title":"Psychiatric symptoms and HPA axis function in adolescent methamphetamine users","volume":"5","author":"King","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0930","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/npp.2014.12","article-title":"Effects of MDMA and intranasal oxytocin on social and emotional processing","volume":"39","author":"Kirkpatrick","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0935","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/brain\/awq103","article-title":"Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography\/[(11)C]DASB and structural brain imaging study","volume":"133","author":"Kish","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0940","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2990.2006.00790.x","article-title":"Single dose of MDMA causes extensive decrement of serotoninergic fibre density without blockage of the fast axonal transport in Dark Agouti rat brain and spinal cord","volume":"33","author":"Kov\u00e1cs","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0945","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.brainresrev.2009.03.002","article-title":"Methamphetamine toxicity and messengers of death","volume":"60","author":"Krasnova","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0950","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1038\/npp.2014.50","article-title":"Incubation of methamphetamine and palatable food craving after punishment-induced abstinence","volume":"39","author":"Krasnova","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0955","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.clinthera.2006.08.004","article-title":"A review of the receptor binding and pharmacokinetic properties of dopamine agonists","volume":"28","author":"Kvernmo","year":"2006","journal-title":"Clin. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0960","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/jnr.22611","article-title":"Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human \u03b1-synuclein","volume":"89","author":"Lam","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0965","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s11064-007-9385-y","article-title":"Inflammation, depression and dementia: are they connected?","volume":"32","author":"Leonard","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0970","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/npp.1994.26","article-title":"MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac)","volume":"10","author":"Leonardi","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0975","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/hup.2335","article-title":"Depression and alterations in hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis function in male abstinent methamphetamine abusers","volume":"28","author":"Li","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0980","first-page":"6","article-title":"Striatal cholinergic interneuron regulation and circuit effects","volume":"21","author":"Lim","year":"2014","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0985","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/0024-3205(83)90344-2","article-title":"Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior","volume":"33","author":"Linnoila","year":"1983","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.pneurobio.2015.09.011_bib0990","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM199403033300907","article-title":"Mechanisms of disease: excitatory amino acids as a final common pathway for neurologic disorders","volume":"330","author":"Lipton","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib0995","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2009.02.056","article-title":"Alpha-synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity","volume":"454","author":"Liu","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1000","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/bph.12519","article-title":"Sex-dependent long-term effects of adolescent exposure to THC and\/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats","volume":"171","author":"Lopez-Rodriguez","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-0173(03)00173-5","article-title":"Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms","volume":"42","author":"Lyles","year":"2003","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1010","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0022-3565(25)20131-8","article-title":"Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat","volume":"278","author":"Malberg","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2007.03.014","article-title":"Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter","volume":"27","author":"Manning-Bo\u011f","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1020","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/sj.npp.1301558","article-title":"Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors","volume":"33","author":"Mart\u00edn","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2015.02.002","article-title":"Methamphetamine decreases CD4 T cell frequency and alters pro-inflammatory cytokine production in a model of drug abuse","volume":"752C","author":"Mata","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1030","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1523\/JNEUROSCI.18-20-08417.1998","article-title":"Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428","volume":"18","author":"McCann","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s002130050967","article-title":"Cognitive performance in (+\/\u2212)3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d) users: a controlled study","volume":"143","author":"McCann","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0893-133X(00)00171-8","article-title":"Caveat emptor: editors beware","volume":"24","author":"McCann","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00213-008-1218-4","article-title":"Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+\/\u2212)3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) users: relationship to cognitive performance","volume":"200","author":"McCann","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00000446-200612000-00024","article-title":"Methamphetamine abuse","volume":"106","author":"McGuinness","year":"2006","journal-title":"Am. J. Nurs."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuropharm.2005.08.006","article-title":"Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines. MDMA (\u201cEcstasy\u201d) and MDA (\u201cLove\u201d)","volume":"50","author":"McNamara","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1060","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0704442","article-title":"The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA \u201cecstasy\u201d) to rats","volume":"135","author":"Mechan","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/exnr.1996.0198","article-title":"Differential abundance of glutamate transporter subtypes in amyotrophic lateral sclerosis (ALS)-vulnerable versus ALS resistant brain stem motor cell groups","volume":"142","author":"Medina","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0006-8993(97)00548-9","article-title":"Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey","volume":"766","author":"Melega","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1075","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/sj.npp.1301502","article-title":"Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles","volume":"33","author":"Melega","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/10673220591003605","article-title":"Implications of chronic methamphetamine use: a literature review","volume":"13","author":"Meredith","year":"2005","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1085","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0022-3565(24)39008-1","article-title":"Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia","volume":"295","author":"Metzger","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijdevneu.2004.04.007","article-title":"Neurotoxic effects of MDMA (\u201cecstasy\u201d) administration to neonatal rats","volume":"22","author":"Meyer","year":"2004","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1095","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1196\/annals.1432.029","article-title":"Development and characterization of a novel animal model of intermittent MDMA (\u201cEcstasy\u201d) exposure during adolescence","volume":"1139","author":"Meyer","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s002130100742","article-title":"The \u201cselective\u201d dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin 2C receptors","volume":"156","author":"Millan","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1021\/tx9501546","article-title":"Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-\u03b1-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats","volume":"9","author":"Miller","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-2999(97)00044-7","article-title":"2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+\/\u2212)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations","volume":"323","author":"Miller","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1749-6632.1996.tb17438.x","article-title":"Neurotoxicity of d-amphetamine in the C57BL\/6J and CD-1 mouse. Interactions with stress and the adrenal system","volume":"801","author":"Miller","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1120","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1017\/S1461145712001356","article-title":"Role of convergent activation of glutamatergic and dopaminergic systems in the nucleus accumbens in the development of methamphetamine psychosis and dependence","volume":"16","author":"Miyazaki","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/157015911795016976","article-title":"Pharmacologic treatment with GABA(B) receptor agonist of methamphetamine-induced cognitive impairment in mice","volume":"9","author":"Mizoguchi","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1130","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/342926a0","article-title":"Multiple D2 dopamine receptors produced by alternative RNA splicing","volume":"342","author":"Monsma","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1135","doi-asserted-by":"crossref","first-page":"14928","DOI":"10.1073\/pnas.93.25.14928","article-title":"Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor","volume":"93","author":"Moratalla","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001756-199612200-00001","article-title":"D1-class dopamine receptors influence cocaine-induced persistent expression of Fos-related proteins in striatum","volume":"8","author":"Moratalla","year":"1996","journal-title":"NeuroReport"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(00)00749-4","article-title":"(+\/\u2212)-3,4-Methylenedioxymethamphetamine (MDMA, \u2018Ecstasy\u2019) increases social interaction in rats","volume":"408","author":"Morley","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.coph.2004.08.007","article-title":"Ecstasy: pharmacology and neurotoxicity","volume":"5","author":"Morton","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnana.2011.00051","article-title":"Striatal signaling in l-DOPA induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation","volume":"5","author":"Murer","year":"2011","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1160","first-page":"151","article-title":"Forensic toxicologic analysis of methamphetamine and amphetamine optical isomers by high performance liquid chromatography","volume":"101","author":"Nagai","year":"1988","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1165","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1038\/sj.npp.1301007","article-title":"Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse","volume":"31","author":"Narita","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1170","series-title":"National Drug Threat Assessment","author":"National Drug Intelligence Center","year":"2007"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1175","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/15622970701870933","article-title":"Hippocampal remodelling after MDMA neurotoxicity: a single case study","volume":"10","author":"Nifosi","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1180","doi-asserted-by":"crossref","first-page":"27230","DOI":"10.1074\/jbc.M212436200","article-title":"Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications","volume":"278","author":"Norris","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1185","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson's disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1190","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0022-3565(25)22433-8","article-title":"Neurotoxicity profiles of substituted amphetamines in the C57BL\/6J mouse","volume":"270","author":"O\u2019Callaghan","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1195","series-title":"Amphetamines. Merck Manual for Health Care Professionals","author":"O\u2019Connor","year":"2012"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1200","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/j.1471-4159.1993.tb13405.x","article-title":"Methamphetamine induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists","volume":"60","author":"O\u2019Dell","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01244869","article-title":"Competitive and noncompetitive N-methyl-d-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions","volume":"92","author":"Ohmori","year":"1993","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1215","doi-asserted-by":"crossref","first-page":"12288","DOI":"10.1523\/JNEUROSCI.2655-10.2010","article-title":"Associative learning and CA3-CA1 synaptic plasticity are impaired in D1R null, Drd1a\u2212\/\u2212 mice and in hippocampal siRNA silenced Drd1a mice","volume":"30","author":"Ortiz","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1220","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jpi.12078","article-title":"Melatonin attenuates methamphetamine-induced disturbances in mitochondrial dynamics and degeneration in neuroblastoma SH-SY5Y cells","volume":"55","author":"Parameyong","year":"2013","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1225","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0361-9230(92)90237-R","article-title":"Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA)","volume":"28","author":"Paris","year":"1992","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s002130100897","article-title":"Recreational Ecstasy\/MDMA and other drug users form the UK and Italy: psychiatric symptoms and psychobiological problems","volume":"159","author":"Parrott","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1235","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00213-003-1600-1","article-title":"The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy\/MDMA users: a rejoinder to Sumnall et al. (2003)","volume":"171","author":"Parrott","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0269881106063268","article-title":"MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress","volume":"20","author":"Parrott","year":"2006","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1245","first-page":"a35","article-title":"Heavy ecstasy\/MDMA use at cool house parties: substantial cortisol release and increased body temperature","volume":"21","author":"Parrott","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000147470","article-title":"Dance clubbing on MDMA and during abstinence from Ecstasy\/MDMA: prospective neuroendocrine and psychobiological changes","volume":"57","author":"Parrott","year":"2008","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1255","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/FBP.0000000000000060","article-title":"MDMA, cortisol, and heightened stress in recreational ecstasy users","volume":"25","author":"Parrott","year":"2014","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1260","first-page":"13","article-title":"Persistent psychosis after a single ingestion of \u201cecstasy\u201d (MDMA)","author":"Patel","year":"2011","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1265","first-page":"00471","article-title":"Immune dysregulation and cognitive vulnerability in the aging brain: interactions of microglia, IL-1\u03b2, BDNF and synaptic plasticity","author":"Patterson","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1270","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0893-133X(01)00334-7","article-title":"Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects","volume":"26","author":"Paulus","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1275","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.pbb.2004.10.001","article-title":"Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period","volume":"79","author":"Piper","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1280","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/dev.20085","article-title":"Repeated MDMA (\u201cecstasy\u201d) exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding","volume":"47","author":"Piper","year":"2005","journal-title":"Dev. Psychobiol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1285","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ntt.2006.10.002","article-title":"A developmental comparison of the neurobehavioral effects of ecstasy (MDMA)","volume":"29","author":"Piper","year":"2007","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1290","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12640-014-9513-9","article-title":"Autophagy inhibition by caffeine increases toxicity of methamphetamine in SH-SY5Y neuroblastoma cell line","volume":"27","author":"Pitaksalee","year":"2015","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1295","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/syn.20733","article-title":"Effects of the endogenous PPAR-alpha agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice","volume":"64","author":"Plaza-Zabala","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1300","first-page":"40","article-title":"Persistent psychosis and medical complications after a single ingestion of MDMA \u201cecstasy\u201d: a case report and review of the literature","volume":"6","author":"Potash","year":"2009","journal-title":"Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1305","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF03033178","article-title":"Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists","volume":"5","author":"Presgraves","year":"2004","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1310","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1476-5381.2010.00663.x","article-title":"Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity","volume":"160","author":"Puerta","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1315","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.toxlet.2014.08.010","article-title":"Insulin-like growth factor binding protein 5 (IGFBP5) mediates methamphetamine-induced dopaminergic neuron apoptosis","volume":"230","author":"Qiao","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1320","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1325","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1007\/BF02854904","article-title":"Causes and consequences of methamphetamine and MDMA toxicity","volume":"8","author":"Quinton","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1330","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-007-0796-x","article-title":"Neurotoxic effects of chronic restraint stress in the striatum of methamphetamine-exposed rats","volume":"193","author":"Quinton","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1335","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/hup.347","article-title":"Investigating the potential neurotoxicity of ecstasy (MDMA): an imaging approach","volume":"16","author":"Reneman","year":"2001","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1340","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(01)06888-X","article-title":"Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons","volume":"358","author":"Reneman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1345","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archpsyc.58.10.901","article-title":"Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or \u201cecstasy\u201d): preliminary findings","volume":"58","author":"Reneman","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1350","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0006-8993(80)90952-X","article-title":"Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study","volume":"193","author":"Ricaurte","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1355","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1988.03410010059035","article-title":"(+\/\u2212)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates","volume":"260","author":"Ricaurte","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1360","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0006-8993(88)91309-1","article-title":"Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration","volume":"446","author":"Ricaurte","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1365","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1002\/jnr.21302","article-title":"Metabolic interactions between glutamatergic and dopaminergic neurotransmitter systems are mediated through D(1) dopamine receptors","volume":"3293","author":"Rodrigues","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1370","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1176\/ajp.2006.163.11.1993","article-title":"Contingency management for the treatment of methamphetamine use disorders","volume":"163","author":"Roll","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1375","doi-asserted-by":"crossref","first-page":"10603","DOI":"10.1523\/JNEUROSCI.0608-14.2014","article-title":"Exogenous \u03b1-synuclein decreases raft partitioning of Cav2.2 channels inducing dopamine release","volume":"34","author":"Ronzitti","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1380","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00213-011-2598-4","article-title":"Behavioural and neuroinflammatory effects of the combination of binge ethanol and MDMA in mice","volume":"221","author":"Ros-Sim\u00f3","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1385","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.1021\/bi00144a010","article-title":"p-Chloroamphetamine induces serotonin release through serotonin transporters","volume":"31","author":"Rudnick","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1390","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biopsych.2014.03.023","article-title":"Activation of DREAM (downstream regulatory element antagonistic modulator), a calcium-binding protein, reduces l-DOPA-induced dyskinesias in mice","volume":"77","author":"Ruiz-DeDiego","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1395","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26197","article-title":"Dopaminergic regulation of olfactory type G-protein \u03b1 subunit expression in the striatum","author":"Ruiz-DeDiego","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1400","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ncl.2011.05.004","article-title":"Neurologic manifestations of chronic methamphetamine abuse","volume":"29","author":"Rusyniak","year":"2011","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1405","series-title":"National Geographic Channel","author":"San Francisco Meth Zombies (TV Documentary)","year":"2013"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1410","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0028-3908(02)00411-2","article-title":"Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats","volume":"44","author":"Sanchez","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1415","first-page":"529","article-title":"Neuropathological evaluation by combined immunohistochemistry and degeneration-specific methods: application to methylenedioxymethamphetamine","volume":"9","author":"Scallet","year":"1988","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1420","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3109\/15563650.2010.516752","article-title":"The clinical toxicology of metamfetamine","volume":"48","author":"Schep","year":"2010","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1425","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0376-8716(98)00051-9","article-title":"MDMA (\u2018ecstasy\u2019) consumption in the context of polydrug abuse: a report on 150 patients","volume":"52","author":"Schifano","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1430","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0014-2999(90)90245-2","article-title":"Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine","volume":"181","author":"Schmidt","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1435","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(97)00173-X","article-title":"Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants","volume":"759","author":"Schmued","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1440","first-page":"251","article-title":"Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction","volume":"163","author":"Seiden","year":"1996","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1445","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.175.1.63","article-title":"Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (\u2018ecstasy\u2019) users","volume":"175","author":"Semple","year":"1999","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1450","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s002130051143","article-title":"A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration","volume":"147","author":"Shankaran","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1455","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/1098-2396(200104)40:1<55::AID-SYN1026>3.0.CO;2-O","article-title":"Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT","volume":"40","author":"Shankaran","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1460","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neuroscience.2013.08.033","article-title":"A stress steroid triggers anxiety via increased expression of \u03b14\u03b2\u03b4 GABAA receptors in methamphetamine dependence","volume":"254","author":"Shen","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1465","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00213-002-1288-7","article-title":"Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats","volume":"165","author":"Shoblock","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1470","first-page":"CD003021","article-title":"Treatment for amphetamine withdrawal","volume":"15","author":"Shoptaw","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1475","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12640-013-9423-2","article-title":"A single neurotoxic dose of methamphetamine induces a long-lasting depressive-like behaviour in mice","volume":"5","author":"Silva","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1480","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuroscience.2007.09.044","article-title":"Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory","volume":"150","author":"Sim\u00f5es","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1485","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0028-3908(99)00076-3","article-title":"Naloxone reverses disinhibitory\/aggressive behavior in 5,7-DHT-lesioned rats; involvement of GABA(A) receptor blockade?","volume":"38","author":"Soderpalm","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1490","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2014.09.010","article-title":"Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(\u2212\/\u2212) aphakia mice","volume":"73","author":"Sol\u00eds","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1495","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0022-3565(25)24344-0","article-title":"Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems","volume":"238","author":"Sonsalla","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1500","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1126\/science.2563176","article-title":"Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity","volume":"243","author":"Sonsalla","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1505","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0022-3565(25)22956-1","article-title":"Competitive and noncompetitive antagonists at N-methyl-d-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice","volume":"256","author":"Sonsalla","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1510","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0006-8993(96)00995-X","article-title":"Treatment of mice with methamphetamine produces cell loss in the substantial nigra","volume":"738","author":"Sonsalla","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1515","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0022-3565(25)09490-X","article-title":"The monoamine oxidase-B inhibitor l-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long term serotonergic deficits","volume":"273","author":"Sprague","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1520","first-page":"427","article-title":"An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine","volume":"19","author":"Sprague","year":"1998","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1525","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/jpet.102.044982","article-title":"Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy)","volume":"305","author":"Sprague","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1531","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1471-4159.2005.03566.x","article-title":"Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha","volume":"96","author":"Sriram","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1530","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/0006-2952(87)90594-6","article-title":"Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain","volume":"36","author":"Steele","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1535","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0301-0082(98)00083-5","article-title":"The role of microglia and macrophages in the pathophysiology of the CNS","volume":"58","author":"Stoll","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1540","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-3565(25)20051-9","article-title":"Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine","volume":"247","author":"Stone","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1545","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.biopsych.2013.05.006","article-title":"l-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice","volume":"75","author":"Su\u00e1rez","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1550","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1555","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4103\/1673-5374.133146","article-title":"Protective effect of alpha-synuclein knockdown on methamphetamine-induced neurotoxicity in dopaminergic neurons","volume":"9","author":"Tai","year":"2014","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1560","article-title":"Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats","author":"Tao","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1565","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/syn.20497","article-title":"Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum","volume":"62","author":"Tata","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1570","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1471-4159.2007.05155.x","article-title":"The newly synthesized pool of dopamine determines the severity of methamphetamine induced neurotoxicity","volume":"105","author":"Thomas","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1575","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1471-4159.2010.06950.x","article-title":"The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum","volume":"115","author":"Thomas","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1580","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1326-8-22","article-title":"Voluntary exercise protects against methamphetamine-induced oxidative stress in brain microvasculature and disruption of the blood\u2013brain barrier","volume":"8","author":"Toborek","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1585","doi-asserted-by":"crossref","first-page":"e56438","DOI":"10.1371\/journal.pone.0056438","article-title":"Illicit stimulant use is associated with abnormal substantia nigra morphology in humans","volume":"8","author":"Todd","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1590","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2131\/jts.38.671","article-title":"c-Fos immunoreactivity of neural cells in intoxication due to high-dose methamphetamine","volume":"38","author":"Tomita","year":"2013","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1595","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0024-3205(02)02450-5","article-title":"Protein kinase C-epsilon protects PC12 cells against methamphetamine-induced death: possible involvement of suppression of glutamate receptor","volume":"72","author":"Uemura","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1601","series-title":"World Drug Report","doi-asserted-by":"crossref","DOI":"10.18356\/bdf42380-en","author":"UNODC","year":"2014"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1600","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/npp.2011.332","article-title":"Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [11C]DASB and [11C]MDL 100907","volume":"37","author":"Urban","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1605","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1017\/S1461145713000850","article-title":"The JNK inhibitor, SP600125, potentiates the glial response and cell death induced bymethamphetamine in the mouse striatum","volume":"17","author":"Urrutia","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1610","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/35041572","article-title":"Distinct functions of the two isoforms of dopamine D2 receptors","volume":"408","author":"Usiello","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1615","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00213-005-0174-5","article-title":"MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment","volume":"189","author":"Verrico","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1620","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/appi.ajp.158.3.377","article-title":"Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers","volume":"158","author":"Volkow","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1625","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1523\/JNEUROSCI.21-23-09414.2001","article-title":"Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence","volume":"21","author":"Volkow","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1630","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.npp.1395197","article-title":"Psychological and cardiovascular effects and short-term sequelae of MDMA (\u201cecstasy\u201d) in MDMA-na\u00efve healthy volunteers","volume":"19","author":"Vollenweider","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1635","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0028-3908(86)90184-X","article-title":"Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ion","volume":"25","author":"Wagner","year":"1986","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pneurobio.2015.09.011_bib1645","doi-asserted-by":"crossref","first-page":"e88642","DOI":"10.1371\/journal.pone.0088642","article-title":"Effect of methamphetamine on the microglial damage: role of potassium channel Kv1.3","volume":"9","author":"Wang","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1650","doi-asserted-by":"crossref","first-page":"131","DOI":"10.15698\/mic2014.04.137","article-title":"The Parkinson's disease-associated protein \u03b1-synuclein disrupts stress signaling \u2013 a possible implication for methamphetamine use?","volume":"1","author":"Wang","year":"2014","journal-title":"Microb. Cell"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1655","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/syn.890110209","article-title":"MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow","volume":"11","author":"Weihmuller","year":"1992","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1660","series-title":"Goodman & Gilman's Pharmacological Basis of Therapeutics","article-title":"Miscellaneous sympathomimetic agonists","author":"Westfall","year":"2010"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1665","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00213-001-0942-9","article-title":"Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration","volume":"159","author":"Winsauer","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1670","first-page":"1169","article-title":"Methamphetamine abuse","volume":"76","author":"Winslow","year":"2007","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1675","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.npp.1300434","article-title":"Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior","volume":"29","author":"Winstanley","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1680","first-page":"34","article-title":"Methamphetamine abuse: an overview for health care professionals","volume":"56","author":"Wolkoff","year":"1997","journal-title":"Hawaii Med. J."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1685","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.taap.2007.01.011","article-title":"Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis","volume":"220","author":"Wu","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1690","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.toxlet.2014.07.026","article-title":"S-Nitrosylating protein disulphide isomerase mediates \u03b1-synuclein aggregation caused by methamphetamine exposure in PC12 cells","volume":"230","author":"Wu","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1695","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pneurobio.2010.04.005","article-title":"The putative neurodegenerative links between depression and Alzheimer's disease","volume":"91","author":"Wuwongse","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1700","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1038\/sj.npp.1301031","article-title":"Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines","volume":"31","author":"Xie","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1705","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/syn.20185","article-title":"Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors","volume":"58","author":"Xu","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1710","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-3565(25)09555-2","article-title":"Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra","volume":"273","author":"Yamamoto","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1715","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevNeurobiol.v17.i2.30","article-title":"Amphetamine neurotoxicity: cause and consequence of oxidative stress","volume":"17","author":"Yamamoto","year":"2005","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1720","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.2009.05141.x","article-title":"Amphetamine toxicities: classical and emerging mechanisms","volume":"1187","author":"Yamamoto","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1725","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.pbb.2007.09.002","article-title":"MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: similarities and differences in behavioral effects in an automated activity apparatus in mice","volume":"88","author":"Young","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1730","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02245159","article-title":"Involvement of dopamine receptor subtypes in mouse thermoregulation","volume":"107","author":"Zarrindast","year":"1992","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.07.040","article-title":"Methamphetamine modulates glutamatergic synaptic transmission in rat primary cultured hippocampal neurons","volume":"1582","author":"Zhang","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2015.09.011_bib1740","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbrc.2006.10.046","article-title":"Methamphetamine induces long-term changes in GABAA receptor alpha2 subunit and GAD67 expression","volume":"351","author":"Zhang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008215001008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008215001008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T02:01:45Z","timestamp":1748656905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008215001008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":349,"alternative-id":["S0301008215001008"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2015.09.011","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2015.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}